What is Cipher Skin?
Founded in 2014, Cipher Skin has carved out a unique niche by developing advanced wearable solutions that quantify human movement with unprecedented precision. The company's core technology integrates seamlessly into rehabilitation, recovery, and athletic performance workflows, effectively digitizing physical therapy and physiological monitoring. By capturing high-fidelity data, Cipher Skin is building the world's first comprehensive database of integrated human movement, providing practitioners and researchers with actionable insights that were previously inaccessible through traditional observation methods. This data-centric approach places the company at the intersection of digital health and big data analytics, offering a scalable solution for enterprise-level health monitoring.
How much funding has Cipher Skin raised?
Cipher Skin has raised a total of $5M across 1 funding round:
Series A
$5M
Series A (2021): $5M with participation from Draper Capital, Tribe Capital Growth Corp I, Boyett Group, and TKC Capital
Key Investors in Cipher Skin
Draper Capital
A venture capital firm focused on identifying and supporting high-growth technology companies with disruptive potential in emerging markets.
Tribe Capital Growth Corp I
A special purpose acquisition vehicle based in San Francisco, focused on identifying and merging with high-potential businesses to facilitate public market entry.
Boyett Group
An investment group providing strategic capital and operational guidance to early-stage and growth-oriented technology enterprises.
What's next for Cipher Skin?
With the recent capital injection, Cipher Skin is expected to prioritize the expansion of its data infrastructure and the commercialization of its wearable ecosystem. The strategic focus will likely shift toward deepening market penetration within the rehabilitation and professional sports sectors, where the demand for objective, biometric-driven recovery metrics is surging. As the company continues to refine its sensor technology, the integration of its proprietary database into broader healthcare systems could redefine standard protocols for patient monitoring and performance optimization. Future growth will be contingent on the firm's ability to maintain its technological edge while navigating the complex regulatory landscape of medical-grade wearable devices.
See full Cipher Skin company page
